319 related articles for article (PubMed ID: 37805491)
1. Exosome, the glass slipper for Cinderella of cancer-bladder cancer?
Yang Y; Miao L; Lu Y; Sun Y; Wang S
J Nanobiotechnology; 2023 Oct; 21(1):368. PubMed ID: 37805491
[TBL] [Abstract][Full Text] [Related]
2. Exosomes in bladder cancer: novel biomarkers and targets.
Geng H; Zhou Q; Guo W; Lu L; Bi L; Wang Y; Min J; Yu D; Liang Z
J Zhejiang Univ Sci B; 2021 May; 22(5):341-347. PubMed ID: 33973417
[TBL] [Abstract][Full Text] [Related]
3. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
5. Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.
Yin C; Liufu C; Zhu T; Ye S; Jiang J; Wang M; Wang Y; Shi B
Int J Nanomedicine; 2024; 19():3677-3695. PubMed ID: 38681092
[TBL] [Abstract][Full Text] [Related]
6. Targeted exosome-based nanoplatform for new-generation therapeutic strategies.
Yin W; Ma H; Qu Y; Wang S; Zhao R; Yang Y; Guo ZN
Biomed Mater; 2024 Mar; 19(3):. PubMed ID: 38471163
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
Xitong D; Xiaorong Z
Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
[TBL] [Abstract][Full Text] [Related]
8. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
Huang CS; Ho JY; Chiang JH; Yu CP; Yu DS
Cells; 2020 Jun; 9(6):. PubMed ID: 32517366
[TBL] [Abstract][Full Text] [Related]
9. Effective internalization of U251-MG-secreted exosomes into cancer cells and characterization of their lipid components.
Toda Y; Takata K; Nakagawa Y; Kawakami H; Fujioka S; Kobayashi K; Hattori Y; Kitamura Y; Akaji K; Ashihara E
Biochem Biophys Res Commun; 2015 Jan; 456(3):768-73. PubMed ID: 25498500
[TBL] [Abstract][Full Text] [Related]
10. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.
Kar R; Dhar R; Mukherjee S; Nag S; Gorai S; Mukerjee N; Mukherjee D; Vatsa R; Chandrakanth Jadhav M; Ghosh A; Devi A; Krishnan A; Thorat ND
ACS Biomater Sci Eng; 2023 Feb; 9(2):577-594. PubMed ID: 36621949
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer.
Shimizu A; Sawada K; Kimura T
Cells; 2020 Mar; 9(4):. PubMed ID: 32230983
[TBL] [Abstract][Full Text] [Related]
12. Challenges in the development and establishment of exosome-based drug delivery systems.
Wang J; Chen D; Ho EA
J Control Release; 2021 Jan; 329():894-906. PubMed ID: 33058934
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
[TBL] [Abstract][Full Text] [Related]
14. Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.
Hiltbrunner S; Mints M; Eldh M; Rosenblatt R; Holmström B; Alamdari F; Johansson M; Veerman RE; Winqvist O; Sherif A; Gabrielsson S
Sci Rep; 2020 Apr; 10(1):5960. PubMed ID: 32249794
[TBL] [Abstract][Full Text] [Related]
15. Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases.
Jiang Y; Wang F; Wang K; Zhong Y; Wei X; Wang Q; Zhang H
Curr Med Chem; 2022; 29(17):3111-3124. PubMed ID: 34477508
[TBL] [Abstract][Full Text] [Related]
16. Roles of Exosomes in Ocular Diseases.
Liu J; Jiang F; Jiang Y; Wang Y; Li Z; Shi X; Zhu Y; Wang H; Zhang Z
Int J Nanomedicine; 2020; 15():10519-10538. PubMed ID: 33402823
[TBL] [Abstract][Full Text] [Related]
17. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
18. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1.
Cai X; Qu L; Yang J; Xu J; Sun L; Wei X; Qu X; Bai T; Guo Z; Zhu Y
Cancer Med; 2020 Aug; 9(16):6009-6019. PubMed ID: 32627968
[TBL] [Abstract][Full Text] [Related]
19. Improvement, scaling-up, and downstream analysis of exosome production.
Jafari D; Malih S; Eini M; Jafari R; Gholipourmalekabadi M; Sadeghizadeh M; Samadikuchaksaraei A
Crit Rev Biotechnol; 2020 Dec; 40(8):1098-1112. PubMed ID: 32772758
[TBL] [Abstract][Full Text] [Related]
20. Exosomes and cancer: from molecular mechanisms to clinical applications.
Jafari A; Babajani A; Abdollahpour-Alitappeh M; Ahmadi N; Rezaei-Tavirani M
Med Oncol; 2021 Mar; 38(4):45. PubMed ID: 33743101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
